Angiotensin II activates NAD(P)H oxidase leading to oxidative stress (Veresh et al., 2008) causing decrease in bioavailability of NO resulting in endothelial dysfunction and vasoconstriction of arterioles leading to hypertension. This evidence concerns the gene FMO5 and endothelial dysfunction.